Active substances
Phosphate sodium monobasic + Sodium phosphate
- SFDA 2
- US price lines 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| FLEET ENEMA | 12.8,10.24 g,g | Enema · Rectal use | 1 Bottle | SAR 16.05 | Generic · OTC | C.P FLIT | Valid |
| FLEET ENEMA | 12.8,10.24 g,g | Enema · Rectal use | 1 Bottle | SAR 15.50 | Generic · OTC | C.P FLIT | Valid |
Indications — CHI Daman Drug Formulary
CONSTIPATION
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | FLEET ENEMA | $0.00954 | per ML | 10 Jul 2026 |
| US NADAC | FLEET ENEMA | $0.00837 | per ML | 10 Jul 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.